title: Management of autoimmune blistering diseases in pregnancy.
abstract: Autoimmune blistering disease (AIBD) in pregnancy raises several complex management issues associated with underlying pathogenesis and treatment options. This article considers the effects of the disease as well as its treatment for both mother and fetus. All AIBDs can occur in pregnancy but are relatively rare. Pemphigoid gestationis is a rare AIBD that is specific to pregnancy. The article considers each AIBD in turn and then looks at treatment options for the group as a whole, as there are many issues common to all.
authors.affiliation: Department of Dermatology, Churchill Hospital, Old Road, Oxford OX3 7LJ, UK. tess.mcpherson@imm.ox.ac.uk
authors.forename: Tess
authors.initials: T
authors.lastname: McPherson
authors.forename: Vanessa V
authors.initials: VV
authors.lastname: Venning
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001768:Blister / Q000188:drug therapy* / Q000276:immunology; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008431:Maternal-Fetal Exchange; D010391:Pemphigoid, Bullous / Q000188:drug therapy* / Q000276:immunology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents